Virtus Fund Advisers’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-535	Closed	-$21.5K	–	109
2023 Q2	$21.5K	Hold	535	–	–	0.15%	93
2023 Q1	$22.8K	Hold	535	–	–	0.16%	93
2022 Q4	$25.7K	Buy	+535	New	+$25.7K	0.18%	88